REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 67 filers reported holding REPARE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.10 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $202,207 | +14.7% | 16,739 | +0.5% | 0.00% | – |
| Q2 2023 | $176,220 | +8.2% | 16,656 | +0.6% | 0.00% | – |
| Q1 2023 | $162,842 | -32.4% | 16,549 | +1.0% | 0.00% | – |
| Q4 2022 | $241,038 | +22.4% | 16,386 | +1.0% | 0.00% | – |
| Q3 2022 | $197,000 | -10.9% | 16,222 | +2.6% | 0.00% | – |
| Q2 2022 | $221,000 | +9.4% | 15,808 | +11.3% | 0.00% | – |
| Q1 2022 | $202,000 | -31.1% | 14,200 | +2.2% | 0.00% | – |
| Q4 2021 | $293,000 | +48.0% | 13,890 | +83.9% | 0.00% | – |
| Q3 2021 | $198,000 | – | 7,551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,532,150 | $86,853,000 | 24.47% |
| MPM ASSET MANAGEMENT LLC | 3,003,772 | $103,029,000 | 14.58% |
| MPM BioImpact LLC | 4,776,674 | $163,840,000 | 14.15% |
| BVF INC/IL | 2,972,191 | $101,946,000 | 4.01% |
| Logos Global Management LP | 676,894 | $23,217,000 | 1.99% |
| Redmile Group, LLC | 2,647,696 | $90,816,000 | 1.10% |
| Orbimed Advisors | 3,426,325 | $117,523,000 | 1.03% |
| CLOUGH CAPITAL PARTNERS L P | 280,979 | $9,638,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 224,300 | $7,693,000 | 0.68% |
| Artal Group S.A. | 570,000 | $19,551,000 | 0.42% |